Mithra Pharmaceuticals S.A. (MITPF)
MITPF Stock Price Chart
Explore Mithra Pharmaceuticals S.A. interactive price chart. Choose custom timeframes to analyze MITPF price movements and trends.
MITPF Company Profile
Discover essential business fundamentals and corporate details for Mithra Pharmaceuticals S.A. (MITPF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
10 Feb 2020
Employees
270.00
Website
https://www.mithra.comCEO
Christophe Marechal
Description
Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Its development candidates include Estelle, which has completed phase III clinical trial, which is a combined oral contraceptive; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a solution for treating menopause and osteoporosis; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it offers NEXTSTELLIS, an oral contraceptive pill. In addition, the company provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. Mithra Pharmaceuticals SA was founded in 1999 and is headquartered in Liège, Belgium.
MITPF Financial Timeline
Browse a chronological timeline of Mithra Pharmaceuticals S.A. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 30 May 2025
Earnings released on 26 Sept 2024
Earnings released on 30 May 2024
Earnings released on 8 Mar 2024
EPS came in at -$1.14 , while revenue for the quarter reached $17.51M .
Earnings released on 30 Dec 2023
EPS came in at -$1.19 , while revenue for the quarter reached $36.56M .
Earnings released on 29 Jun 2023
EPS came in at -$0.96 , while revenue for the quarter reached $7.67M .
Earnings released on 31 Mar 2023
EPS came in at -$0.48 , while revenue for the quarter reached $3.82M .
Earnings released on 7 Mar 2023
EPS came in at -$0.26 , while revenue for the quarter reached $27.26M .
Earnings released on 30 Dec 2022
EPS came in at -$0.56 , while revenue for the quarter reached $59.55M .
Earnings released on 23 Sept 2022
Revenue for the quarter reached $11.95M , missing expectations by -32.94%.
Earnings released on 29 Jun 2022
EPS came in at -$0.73 , while revenue for the quarter reached $11.90M .
Earnings released on 8 Mar 2022
Earnings released on 30 Dec 2021
EPS came in at -$1.61 , while revenue for the quarter reached $11.96M .
Earnings released on 24 Sept 2021
Revenue for the quarter reached $14.29M .
Earnings released on 29 Jun 2021
EPS came in at -$1.51 , while revenue for the quarter reached $14.40M .
Earnings released on 9 Mar 2021
Earnings released on 30 Dec 2020
EPS came in at -$1.66 , while revenue for the quarter reached $7.98M .
Earnings released on 24 Sept 2020
Revenue for the quarter reached $2.81M .
MITPF Stock Performance
Access detailed MITPF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.